Table 3

Lipid coronary heart disease risk factor changes during the 12-week study
Intervention Week 11 Week 12 P-value2 P-value3 Change4 P-value5
Total cholesterol (mg/dl) ADF 201 ± 9 175 ± 12 <0.01 0.12 -26 ± 6 0.50
Control 211 ± 11 202 ± 9 0.54 -9 ± 5
LDL cholesterol (mg/dl) ADF 118 ± 9 99 ± 9 0.01 0.82 -18 ± 6 0.29
Control 128 ± 10 119 ± 6 0.08 -9 ± 4
HDL cholesterol (mg/dl) ADF 56 ± 3 54 ± 4 0.49 0.77 -2 ± 3 0.51
Control 57 ± 2 58 ± 4 0.83 1 ± 2
Triacylglycols (mg/dl) ADF 109 ± 13 87 ± 9 0.06 0.01 -22 ± 11 0.22
Control 108 ± 18 118 ± 19 0.34 10 ± 7
Non-HDL cholesterol (mg/dl) ADF 149 ± 11 124 ± 12 <0.01 0.54 -25 ± 5 0.96
Control 153 ± 12 144 ± 10 0.79 -9 ± 5
LDL particle size (Å) ADF 254 ± 1 258 ± 2 <0.01 <0.01 4 ± 1 0.13
Control 252 ± 2 250 ± 3 0.16 -2 ± 1

Values reported as mean ± SEM. ADF: Alternate day fasting.

1Baseline values were not significantly different between intervention groups for any parameter: Independent samples t-test.

2P-value between week 1 and week 12: Paired t-test.

3P-value between groups at week 12: Independent samples t-test.

4Absolute change between week 1 and week 12 values.

5P-value between groups for absolute change: Independent samples t-test.

Varady et al.

Varady et al. Nutrition Journal 2013 12:146   doi:10.1186/1475-2891-12-146

Open Data